The Donor Selection & Cell Source Summit, hosted by Hanson Wade, brings together leaders from industry and academia to address critical bottlenecks in donor screening, cell sourcing, and process ...
MiNK-215, an IL-15 armoured FAP-targeting CAR-iNKT, targets and clears tumor-protective FAP+ fibroblasts to allow immune cells to infiltrate and ...
The field of tissue-immune interactions has undergone significant transformation as emerging evidence demonstrates the centrality of local microenvironments ...
Cancer immunology research has increasingly focused on the complex interactions between oncogenic drivers, such as KRAS mutations, and the tumor ...
By fusing enzyme fragments to antibodies, researchers from Institute of Science Tokyo, Japan, developed an innovative enzyme ...
Epstein-Barr virus reprograms autoreactive B cells, possibly contributing to systemic lupus erythematosus, with infected B cells in patients showing high antigen-presenting capabilities.
Discover why Cartesian Therapeutics, Inc. earns a Buy rating with strong CAR-T pipeline progress and market growth in ...
In this video, Catherine S. Diefenbach, MD, discusses the differences between three FDA-approved CD19-directed chimeric antigen receptor T-cell therapy products for the treatment of lymphoma.
Lonza helps biotech firms accelerate from DNA to IND with tailored strategies that reduce risk and speed complex biologics to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback